10 Johnson & Johnson marketing leaders

Two launch leads, for Tremfya in IBD and for icotrokinra, sit in this Johnson & Johnson marketing group alongside people who have held vice president titles in immunology, pulmonary hypertension, biosurgery and metabolism, director titles in neuroscience and prostate, and a head of marketing for genito-urinary oncology. They suit a healthcare company planning a launch in a competitive category or deciding how US and global brand teams split the work.

10 professionals3 companiesData retrieved October 3, 2026

Professionals to explore

  1. Alison James

    LinkedIn

    Experience: Vice President Global Marketing - Biosurgery · Johnson & Johnson MedTech

    $1,010 per 30-minute call

    Alison James became Vice President Global Marketing - Biosurgery at Johnson & Johnson MedTech in 2026 and also holds Senior Director of US Marketing, ETHICON (since 2024) and Business Unit Director (since 2014) at Johnson & Johnson. Alison was EMEA Marketing Manager (2012-2014) and in Sales Management (2010-2012) there, the one MedTech marketer here and a fit for biosurgery marketing questions.

    Is this you? Claim your profile and get paid for calls.

  2. Candice Long

    LinkedIn

    Experience: Former Vice President, Immunology Marketing · Johnson & Johnson Innovative Medicine

    $1,010 per 30-minute call

    Candice Long was Vice President, Immunology Marketing at Johnson & Johnson Innovative Medicine (2016-2020) and since 2023 has been Worldwide VP, Immunology, Global Strategic Commercial Organization, leading global commercial efforts for Janssen's Immunology portfolio and pipeline. Other titles there include President, Janssen U.S. Infectious Diseases & Vaccines (2020-2022) and Worldwide Vice President, Infectious Disease and Vaccines (2014-2016), a fit for immunology portfolio strategy questions.

    Is this you? Claim your profile and get paid for calls.

  3. Heidi McNeill

    LinkedIn

    Experience: Head of Marketing (Genito-urinary Oncology) · Johnson & Johnson Innovative Medicine

    $740 per 30-minute call

    Heidi McNeill, based in London, has been Head of Marketing (Genito-urinary Oncology) at Johnson & Johnson Innovative Medicine since 2024, after Senior Product Manager - Prostate Cancer portfolio at The Janssen Pharmaceutical Companies of Johnson & Johnson (2018-2024). Heidi was Marketing Manager at Shield Therapeutics plc (2017-2018) and Marketing Manager - CNS at Otsuka Pharmaceuticals (UK) Ltd (2012-2016), useful for oncology brand questions.

    Is this you? Claim your profile and get paid for calls.

  4. Jessica Phaup

    LinkedIn

    Experience: Head of Icotrokinra I Director of Marketing · Johnson & Johnson

    $606 per 30-minute call

    As US Launch Lead and P&L owner, Jessica Phaup is charged with the launch of icotrokinra, described as the first targeted oral peptide across a number of immune-mediated diseases, as Head of Icotrokinra I Director of Marketing at Johnson & Johnson (since 2025). Jessica was Franchise Head, ANDEXXA and Acute Care Sales (2021-2025) and Executive Director, Head of Roxadustat (2021-2022) at AstraZeneca, a fit for launch P&L questions.

    Is this you? Claim your profile and get paid for calls.

  5. Karen Meagher

    LinkedIn

    Experience: Marketing Director Neuroscience · Johnson & Johnson Innovative Medicine

    $471 per 30-minute call

    Based in the Greater Toronto Area, Karen Meagher is Marketing Director Neuroscience at Johnson & Johnson Innovative Medicine (since 2023) and Marketing Director, Neuroscience and Vaccines at The Janssen Pharmaceutical Companies of Johnson & Johnson (since 2021). Karen's Janssen titles also include Marketing Director, IBD (2019-2021) and Marketing Manager Dermatology (2015-2019), a fit for neuroscience brand marketing questions.

    Is this you? Claim your profile and get paid for calls.

  6. Kate Hensman

    LinkedIn

    Experience: Senior Director of Marketing, US Prostate Portfolio · Johnson & Johnson Innovative Medicine

    $606 per 30-minute call

    Kate Hensman's Johnson & Johnson Innovative Medicine titles cross three markets: Senior Director of Marketing, US Prostate Portfolio (since 2024), Business Unit Director, Immunology Canada (2023-2024), Business Unit Director, Rheumatology & Dermatology Canada (2022-2023), Business Unit Director Rare Disease, ANZ (2020-2022) and Marketing Lead Rare Disease ANZ (2020). That spread suits questions on adapting brand plans across country markets.

    Is this you? Claim your profile and get paid for calls.

  7. Priscilla Bottmann

    LinkedIn

    Experience: Vice President, Marketing & Sales, Pulmonary Hypertension · Johnson & Johnson Innovative Medicine

    $1,010 per 30-minute call

    Priscilla Bottmann has been Vice President, Marketing & Sales, Pulmonary Hypertension at Johnson & Johnson Innovative Medicine since 2024, and their LinkedIn profile also gives the title U.S. Vice President, Marketing, Franchise Strategy & Key Account Management, Neuroscience. That pairing of marketing with sales and key account management suits questions on how marketing and field teams work together on a brand.

    Is this you? Claim your profile and get paid for calls.

  8. Sarah Brennan

    LinkedIn

    Experience: Former Vice President, Sales & Marketing Metabolism · Johnson & Johnson Innovative Medicine

    $1,010 per 30-minute call

    Sarah Brennan held Vice President, Sales & Marketing Metabolism (2016-2018), Director of Marketing, Bapineuzumab (2011-2012) and VP, Business Development, Cardiovascular, Metabolism and Retina (2018-2021) at Johnson & Johnson Innovative Medicine. Today Sarah is Company Group Chairman, Global Commercial Strategy Organization (since 2024) and Head, Commercial Strategy & Operations (since 2021), a fit for questions on how commercial strategy shapes the portfolio.

    Is this you? Claim your profile and get paid for calls.

  9. Susanne Cullmann

    LinkedIn

    Experience: US Group Product Director, HCP Marketing and Launch Lead, GI Tremfya · Johnson & Johnson Innovative Medicine

    $539 per 30-minute call

    Susanne Cullmann describes leading the HCP marketing side of the Tremfya launch in the hypercompetitive IBD category, as US Group Product Director, HCP Marketing and Launch Lead, GI Tremfya (since 2022). Earlier titles were Global Director HCP & Consumer, Multiple Sclerosis Ponvory (2020-2022) and Global Marketing Director, Cough & Cold Tylenol Cold, Sudafed at Johnson & Johnson (2016-2020), a fit for launch planning in crowded categories.

    Is this you? Claim your profile and get paid for calls.

  10. Tom Mickelson

    LinkedIn

    Experience: Former Head of US Dermatology Marketing · Johnson & Johnson Innovative Medicine

    $740 per 30-minute call

    Tom Mickelson was Head of US Dermatology Marketing at Johnson & Johnson Innovative Medicine (2021-2023), then Vice President, Global Commercial Lead - Dermatology & Rheumatology (2023-2024) and, since 2024, Vice President, Global Commercial Lead - Autoantibody & Rheumatology Portfolio. Before J&J, Tom was US Immunology Marketing Leader (2019-2021) and US Pain Marketing Leader (2018-2019) at Eli Lilly and Company, useful for US-versus-global brand questions.

    Is this you? Claim your profile and get paid for calls.

Choose the right perspective

For launch planning, Susanne Cullmann (Tremfya in IBD) and Jessica Phaup (icotrokinra) are the closest fit. Candice Long, Sarah Brennan and Tom Mickelson now hold global commercial roles, useful for how US and global teams split brand strategy; Kate Hensman and Heidi McNeill cover prostate and genito-urinary oncology, and Alison James is the pick for MedTech biosurgery marketing.

Questions to take into the conversation

  1. 01How should a launch team split HCP and consumer marketing for a new immunology medicine entering a crowded category?
  2. 02What does a US launch lead own on the P&L, and what stays with the global commercial team?
  3. 03How does marketing a biosurgery product differ from marketing a prescription medicine?

About this directory

This is a professional research starting point based on business profile data retrieved on . Titles and companies reflect that source snapshot; roles marked former had ended by then. Check the linked profiles for current details. Inclusion does not imply Instant Expert membership or availability.

Other perspectives in Pharmaceuticals